PTK2 and prostate cancer: Further, nordihydroguaiaretic acid (NDGA) (>10 μM) was able to inhibit cell migration by suppressing NRP1 expression and function, leading to attenuated cell motility, cell adhesion to ECM and FAK signaling in prostate cancer cells in vitro and in vivo [213].